Literature DB >> 35578820

Tofacitinib for Treatment of Alopecia Areata: Real-world Evidence and Factors Associated with Therapeutic Response.

Manuel Sanchez-Diaz1, Pablo Diaz-Calvillo, Juan-Angel Rodriguez-Pozo, Jesús Tercedor-Sánchez, Maria-Rosa Cantudo-Cuenca, Alejandro Molina-Leyva, Salvador Arias-Santiago.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35578820      PMCID： PMC9574676          DOI： 10.2340/actadv.v102.2036

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  15 in total

1.  SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss.

Authors:  Elise A Olsen; Douglas Canfield
Journal:  J Am Acad Dermatol       Date:  2016-12       Impact factor: 11.527

Review 2.  Tofacitinib: A Review in Rheumatoid Arthritis.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

Review 3.  Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.

Authors:  Lucy Yichu Liu; Brett Andrew King
Journal:  J Investig Dermatol Symp Proc       Date:  2018-01

4.  Combined intravenous pulse and topical corticosteroid therapy for severe alopecia areata in children: Comparison of two regimens.

Authors:  Jovan Lalosevic; Mirjana Gajic-Veljic; Branka Bonaci-Nikolic; Milica Stojkovic Lalosevic; Milos Nikolic
Journal:  Dermatol Ther       Date:  2019-10-18       Impact factor: 2.851

5.  Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.

Authors:  Lucy Y Liu; Brittany G Craiglow; Feng Dai; Brett A King
Journal:  J Am Acad Dermatol       Date:  2016-11-02       Impact factor: 11.527

6.  A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata.

Authors:  Masahiro Kurosawa; Satoshi Nakagawa; Masato Mizuashi; Yoshinori Sasaki; Maki Kawamura; Makiko Saito; Setsuya Aiba
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

7.  Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.

Authors:  Milène Kennedy Crispin; Justin M Ko; Brittany G Craiglow; Shufeng Li; Gautam Shankar; Jennifer R Urban; James C Chen; Jane E Cerise; Ali Jabbari; Mårten Cg Winge; M Peter Marinkovich; Angela M Christiano; Anthony E Oro; Brett A King
Journal:  JCI Insight       Date:  2016-09-22

8.  Methotrexate for alopecia areata: A systematic review and meta-analysis.

Authors:  Kevin Phan; Vignesh Ramachandran; Deshan Frank Sebaratnam
Journal:  J Am Acad Dermatol       Date:  2018-07-10       Impact factor: 11.527

9.  Combination tofacitinib and oral minoxidil treatment for severe alopecia areata.

Authors:  Carlos G Wambier; Brittany G Craiglow; Brett A King
Journal:  J Am Acad Dermatol       Date:  2019-09-06       Impact factor: 11.527

10.  Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.

Authors:  Brett King; Justin Ko; Seth Forman; Manabu Ohyama; Natasha Mesinkovska; Guanglei Yu; Jill McCollam; Margaret Gamalo; Jonathan Janes; Emily Edson-Heredia; Katrin Holzwarth; Yves Dutronc
Journal:  J Am Acad Dermatol       Date:  2021-06-16       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.